Pfizer Inc (PFE) — Technical state
As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Signal: Uptrend stack intact — Trades +4.8% vs the 50-day and +11.9% vs the 200-day average, 3.4% below the 52-week high and +28.5% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes. (as of 2026-11-03)
- Trend: Pfizer Inc trades 4.8% above its 50-day and 11.9% above its 200-day moving average. (as of 2026-11-03)
Pfizer discovers, develops, manufactures and sells biopharmaceutical products worldwide, organised into three segments: Biopharma, PC1 and Pfizer Ignite. Its brands cover internal medicine such as Eliquis and Nurtec, vaccines such as Prevnar and Abrysvo, inflammation and immunology treatments such as Xeljanz and Enbrel, rare disease medicines such as Vyndaqel, oncology therapies such as Ibrance and Xtandi, and biosimilars and sterile injectables.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the PFE overview. Research diary readings, not advice.
Trades +4.8% vs the 50-day and +11.9% vs the 200-day average, 3.4% below the 52-week high and +28.5% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day+1.8%
- vs 50-day+4.8%
- vs 200-day+11.9%
- 52-week band3.4% off the high · +28.5% off the low
- Streak1 consecutive down session
- CrossoverGolden cross 39 sessions ago
- 50-day crossprice crossed up through the 50-day 65 sessions ago
- Stochastic%K 42.6 · %D 86 · bear cross
Continue: the PFE chart & overview · the signal board
FAQ · from the current data · as of 2026-11-03
Quick answers
What is the current Closelooknet signal on PFE?
Uptrend stack intact — Trades +4.8% vs the 50-day and +11.9% vs the 200-day average, 3.4% below the 52-week high and +28.5% off the 52-week low; a golden cross printed 39 sessions ago. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is PFE above its 50-day and 200-day moving averages?
As of 2026-11-03, Pfizer Inc trades +4.8% above its 50-day and +11.9% above its 200-day average, with the 20-day +1.8% away.
How far is PFE from its 52-week high?
3.4% below the 52-week high and 28.5% above the 52-week low, as of 2026-11-03.
Mentioned on Closelooknet
Where PFE appears in the diary — 7 pieces, newest first. Every link is our own writing.
Go deeper
Dailies
- Rubin surges as vol complex splits and Europe extends gains
- Layer-1 chips surge as Europe and US futures fade
The reading sits just above the neutral midpoint, consistent with a market that has bounced but not yet committed to a sustained risk-on regime. §11 — Pattern Scanner Active 28 signals · PFE 36 🟡 support-confluence · MCD 36 🟡…
- Narrow tape: Rubin leads as broad market softens across asset classes
The Pattern Scanner shows 28 active signals, all support-confluence, with defensive names (PFE, MCD, NOC, LMT, HD) testing support in red regimes.
- Vol complex splits as bond stress offsets equity calm
Four of five carry a 🔴 regime label (NOC, MCD, UL, LMT); only PFE (🟡, 47% confidence) prints caution rather than outright stress.
- Friday flips broadly risk-off — Korea −6.1%, Temperature still 57
Pattern Scanner: 25 active signals, top-5 all support-confluence — PFE 47 (🟡), NOC 38 (🔴), MCD 37 (🔴), AZN 36 (🟡), UL 29 (🔴) — three red, two yellow, zero green.
- Temperature 59 — Rubin surges 25% monthly as cointegration breaks pile up
The top five hits are all support-confluence reads — NOC, MCD, PFE, JNJ, and MA — with the two highest-confidence names, NOC and MCD, carrying red-regime labels.
- Temperature 59 — first crack in semis, defensives bid
The Pattern Scanner registered 28 active signals, top five clustered in support-confluence setups: NOC at 41 confidence and MCD at 37, both in red regimes, alongside PFE and JNJ in yellow.
Related in the Closelooknet universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AMGN Amgen Incindustry
- NVO Novo Nordisk A/Sindustry
- GILD Gilead Sciences Incindustry
- BIIB Biogen Incindustry
- SNY Sanofi ADRindustry
- ABBV AbbVie Incindustry
- OGN Organon & Coindustry
- JNJ Johnson & Johnsonindustry
- BMY Bristol-Myers Squibb Companyindustry
- MRK Merck & Company Incindustry
- 002422.SHE Sichuan Kelun Pharmaceutical Co Ltdindustry
- AZN AstraZeneca PLCindustry
- CMHC.SW COSMO N NVindustry
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector
- ARGX argenx NV ADRsector